Search results
16 gru 2021 · Background: The major reasons to treat sarcoidosis are to lower the morbidity and mortality risk or to improve quality of life (QoL). The indication for treatment varies depending on which manifestation is the cause of symptoms: lungs, heart, brain, skin or other manifestations.
- Treatment of Sarcoidosis: A Multidisciplinary Approach - PMC
Management of patients with sarcoidosis often requires a...
- Treatment of Sarcoidosis: A Multidisciplinary Approach - PMC
Management of patients with sarcoidosis often requires a multidisciplinary approach: treatment of symptomatic granulomatous inflammation, assessment of comorbid conditions, and tempering of immunosuppressive toxicities.
15 maj 2016 · Learn about the diagnosis and management of sarcoidosis, a multisystem granulomatous inflammatory disease of unknown etiology. Find evidence-based recommendations, consensus guidelines, and expert opinions on corticosteroids, methotrexate, and tumor necrosis factor-alpha inhibitors.
8 wrz 2021 · Given the unpredictable clinical course and uncertainty about adequate treatment approaches, the management of sarcoidosis remains challenging. 5,6 A recent report provides an excellent summary...
29 lis 2022 · We focus on pulmonary sarcoidosis, highlighting recent and established concepts in disease mechanisms, the diversity of the clinical course, including possible ‘subtypes’ of sarcoidosis, and how to measure disease activity. We discuss the principles guiding therapeutic intervention and summarise the more recent clinical trials in sarcoidosis.
11 lip 2024 · Sarcoidosis is a diagnosis of exclusion of granulomatous lung diseases, including tuberculosis and histoplasmosis. Typical history is essential to establish the diagnosis, and biopsy from affected organs is often required. Treated with topical corticosteroids for mild local cutaneous disease.
18 lis 2020 · Treatment is directed at alleviating organ dysfunction, preventing irreversible scarring, and improving quality of life. Herein, we review the indications for treatment, pharmacotherapy, treatment duration, side effects, adjunct non-pharmacologic therapies, and outcomes for patients.
